chr2-96341891-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015341.5(NCAPH):c.269G>A(p.Ser90Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000312 in 1,608,518 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015341.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCAPH | NM_015341.5 | c.269G>A | p.Ser90Asn | missense_variant | 2/18 | ENST00000240423.9 | NP_056156.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCAPH | ENST00000240423.9 | c.269G>A | p.Ser90Asn | missense_variant | 2/18 | 1 | NM_015341.5 | ENSP00000240423.4 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000202 AC: 50AN: 247612Hom.: 0 AF XY: 0.000223 AC XY: 30AN XY: 134230
GnomAD4 exome AF: 0.000321 AC: 468AN: 1456334Hom.: 1 Cov.: 31 AF XY: 0.000311 AC XY: 225AN XY: 724158
GnomAD4 genome AF: 0.000223 AC: 34AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2022 | The c.269G>A (p.S90N) alteration is located in exon 2 (coding exon 2) of the NCAPH gene. This alteration results from a G to A substitution at nucleotide position 269, causing the serine (S) at amino acid position 90 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at